Product Information
INFLECTRA 100 MG VIAL is a brand biologic product labeled by Pfizer Inc., priced at $491.5457 per EA under NDC 00069080901. Its NADAC has been published 26 times since Oct 23, 2024.
Strength
100 mg/10mL
Manufacturer
Pfizer Inc.NDC
00069080901
Classification
Brand Biologic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Last Updated
3/19/2025
Active Ingredients
INFLIXIMABApproval Type
Biologic (BLA)
FDA Application
BLA125544On Market Since
11/21/2016
Pharmacological Classes
Price Statistics
The NADAC for INFLECTRA 100 MG VIAL has been published 26 times since Oct 23, 2024, and over the history we have for it it has declined 14.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $491.5457 per EA |
|---|---|
| All-time high | $577.3460 (Dec 11, 2024) |
| All-time low | $491.5457 (Mar 19, 2025) |
| Median price | $504.5217 |
| Average price | $524.4338 |
| Largest weekly change | -12.6% (Dec 18, 2024) |
| Weeks tracked | 26 |
| Tracking since | Oct 23, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the infliximab-dyyb market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of INFLECTRA 100 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for INFLECTRA 100 MG VIAL, manufactured by Pfizer Inc., is $491.5457 per EA (NDC 00069080901), effective Apr 16, 2025.
How has the price of INFLECTRA 100 MG VIAL changed over time?
Over the history we have for it, the NADAC for INFLECTRA 100 MG VIAL has declined 14.9%. It has been tracked across 26 weekly CMS publications since Oct 23, 2024.
What are the highest and lowest recorded NADAC prices for INFLECTRA 100 MG VIAL?
Since Oct 23, 2024, the NADAC for INFLECTRA 100 MG VIAL has ranged from a low of $491.5457 (Mar 19, 2025) to a high of $577.3460 (Dec 11, 2024), with a median of $504.5217 per EA.
Are there cheaper alternatives to INFLECTRA 100 MG VIAL?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of INFLECTRA 100 MG VIAL, so no direct lower-cost alternative is listed.
Who manufactures INFLECTRA 100 MG VIAL?
INFLECTRA 100 MG VIAL (NDC 00069080901) is labeled by Pfizer Inc., and CMS classifies it as a brand biologic product.
Related Drugs
Same classification